Review article · 2022

Antibody-drug conjugates: Resurgent anticancer agents with multi-targeted therapeutic potential

Claudia Ceci, Pedro Miguel Lacal, Grazia Graziani

Pharmacology & Therapeutics, 236, 108106 · Published 3 January 2022 · DOI 10.1016/j.pharmthera.2021.108106

View at the publisherCite this paper

In brief

“Antibody-drug conjugates: Resurgent anticancer agents with multi-targeted therapeutic potential” is a 2022 review article by Claudia Ceci and 2 co-authors, published in Pharmacology & Therapeutics. OpenAlex counts 39 citations as of 21 November 2026, which puts it in the top 4% of works published in 2022 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
39
Most cited in
2024 (10)
Field-weighted impact
0.84
References
421
Authors
3

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Ceci, C., Lacal, P. M., & Graziani, G. (2022). Antibody-drug conjugates: Resurgent anticancer agents with multi-targeted therapeutic potential. Pharmacology & Therapeutics, 236, 108106. https://doi.org/10.1016/j.pharmthera.2021.108106

MLA 9

Ceci, Claudia, et al. “Antibody-drug conjugates: Resurgent anticancer agents with multi-targeted therapeutic potential.” Pharmacology & Therapeutics, vol. 236, 2022, p. 108106. https://doi.org/10.1016/j.pharmthera.2021.108106.

Chicago

Ceci, Claudia, Pedro Miguel Lacal, and Grazia Graziani. 2022. “Antibody-drug conjugates: Resurgent anticancer agents with multi-targeted therapeutic potential.” Pharmacology & Therapeutics 236: 108106. https://doi.org/10.1016/j.pharmthera.2021.108106.

Harvard

Ceci, C., Lacal, P. M. and Graziani, G. (2022) ‘Antibody-drug conjugates: Resurgent anticancer agents with multi-targeted therapeutic potential’, Pharmacology & Therapeutics, 236, p. 108106. doi:10.1016/j.pharmthera.2021.108106.

IEEE

C. Ceci, P. M. Lacal, and G. Graziani, “Antibody-drug conjugates: Resurgent anticancer agents with multi-targeted therapeutic potential,” Pharmacology & Therapeutics, vol. 236, p. 108106, 2022, doi: 10.1016/j.pharmthera.2021.108106.

BibTeX

@article{ceci2022antibody,
  title     = {{Antibody-drug conjugates: Resurgent anticancer agents with multi-targeted therapeutic potential}},
  author    = {Ceci, Claudia and Lacal, Pedro Miguel and Graziani, Grazia},
  journal   = {Pharmacology \& Therapeutics},
  year      = {2022},
  volume    = {236},
  pages     = {108106},
  doi       = {10.1016/j.pharmthera.2021.108106},
  url       = {https://doi.org/10.1016/j.pharmthera.2021.108106}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202299
202377
20241010
20251010
202633

Its field-weighted citation impact is 0.84: it has been cited 0.84 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research

  • antibody-drug conjugates
  • anticancer agents
  • tumor targeting
  • linker stability
  • drug resistance
  • tumor microenvironment
  • antibody engineering
  • cytotoxic payloads

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Ceci, C., Lacal, P. M., & Graziani, G. (2022). Antibody-drug conjugates: Resurgent anticancer agents with multi-targeted therapeutic potential. Pharmacology & Therapeutics, 236, 108106. https://doi.org/10.1016/j.pharmthera.2021.108106

How many times has this paper been cited?

39 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Claudia Ceci, Pedro Miguel Lacal, Grazia Graziani.

What is the DOI of this paper?

10.1016/j.pharmthera.2021.108106, permanently at https://doi.org/10.1016/j.pharmthera.2021.108106. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.